{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:40:09Z","timestamp":1762540809172,"version":"3.41.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Epidermodysplasia verruciformis (EV) is a rare dermatologic disorder that is characterized by skin-colored-to-light brown flat, discrete or confluent papules resembling verruca plana. EV is divided into 2 forms: a classical genetic form and an acquired form. Classical genetic EV is caused by mutations in <jats:italic toggle=\"yes\">EVER1<\/jats:italic> and <jats:italic toggle=\"yes\">EVER2<\/jats:italic> genes. Acquired EV develops in immunocompromised patients such as HIV-positive patients and transplant recipients. Patients with a prior history of hematopoietic stem cell transplantation (HSCT) have tendency to develop generalized verrucosis. We report an extraordinary case of disseminated epidermodysplasia verruciformis seen in a 7-year-old boy diagnosed with severe combined immunodeficiency syndrome who had undergone HSCT. He had plane, brown papules involving his face, forearms, neck, anterior chest, nape, back, and knees. Cutaneous biopsy showed typical characteristic findings of EV: large cells with gray\u2013blue cytoplasm and keratohyaline granules of different sizes in the granular and spinous layers. Herein, we present an unusual case of disseminated EV in a HSCT patient with typical histopathologic findings and treatment options.<\/jats:p>","DOI":"10.1097\/dad.0000000000001918","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T06:55:27Z","timestamp":1614236127000},"page":"e65-e67","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Epidermodysplasia Verruciformis After Hematopoietic Stem Cell Transplantation in a Patient With Severe Combined Immunodeficiency Syndrome"],"prefix":"10.1097","volume":"43","author":[{"given":"Ecem","family":"Bostan","sequence":"first","affiliation":[{"name":"Dermatology and Venereology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neslihan","family":"Akdogan","sequence":"additional","affiliation":[{"name":"Dermatology and Venereology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozay","family":"Gokoz","sequence":"additional","affiliation":[{"name":"Pathology, Hacettepe University, School of Medicine, Ankara, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"18s","DOI":"10.1038\/jid.1984.15","article-title":"Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses","volume":"83","author":"Lutzner","year":"1984","journal-title":"J Invest Dermatol."},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jid.2018.07.010","article-title":"Epidermodysplasia verruciformis: genetic heterogeneity and EVER1 and EVER2 mutations revealed by genome-wide analysis","volume":"139","author":"Youssefian","year":"2019","journal-title":"J Invest Dermatol."},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1044","article-title":"Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis","volume":"32","author":"Ramoz","year":"2002","journal-title":"Nat Genet."},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaad.2008.08.035","article-title":"Acquired epidermodysplasia verruciformis","volume":"60","author":"Rogers","year":"2009","journal-title":"J Am Acad Dermatol."},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaad.2010.12.011","article-title":"Generalized verrucosis: a review of the associated diseases, evaluation, and treatments","volume":"66","author":"Sri","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/ijd.14196","article-title":"A novel approach to the classification of epidermodysplasia verruciformis","volume":"57","author":"Huang","year":"2018","journal-title":"Int J Dermatol."},{"key":"R7-20250616","first-page":"701","article-title":"Acquired epidermodysplasia verruciformis and its relationship to immunosuppressive therapy: report of a case and review of the literature","volume":"16","author":"Ovits","year":"2017","journal-title":"J Drugs Dermatol."},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(04)16457-X","article-title":"Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency","volume":"363","author":"Laffort","year":"2004","journal-title":"Lancet"},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/adc.84.2.169","article-title":"Severe combined immunodeficiency--molecular pathogenesis and diagnosis","volume":"84","author":"Gaspar","year":"2001","journal-title":"Arch Dis Child."},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/DAD.0000000000001696","article-title":"Acquired epidermodysplasia verruciformis in the setting of renal transplant","volume":"43","author":"Henning","year":"2021","journal-title":"Am J Dermatopathol."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/ajd.12684","article-title":"A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination","volume":"59","author":"Maor","year":"2018","journal-title":"Australas J Dermatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:06:01Z","timestamp":1750100761000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000001918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001918","relation":{},"ISSN":["0193-1091"],"issn-type":[{"type":"print","value":"0193-1091"}],"subject":[],"published":{"date-parts":[[2021,2,8]]}}}